2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

Identification

Generic Name
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
DrugBank Accession Number
DB08398
Background

PhIP (2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) has been used in trials studying the basic science of Pancreas Cancer.

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 224.2612
Monoisotopic: 224.106196404
Chemical Formula
C13H12N4
Synonyms
  • 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
  • PhIP

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UEstrogen receptor alphaNot AvailableHumans
UNuclear receptor coactivator 2Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pyridines and derivatives
Sub Class
Phenylpyridines
Direct Parent
Phenylpyridines
Alternative Parents
Imidazopyridines / N-substituted imidazoles / Benzene and substituted derivatives / Aminoimidazoles / Heteroaromatic compounds / Azacyclic compounds / Primary amines / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
3-phenylpyridine / Amine / Aminoimidazole / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenoid / Heteroaromatic compound / Hydrocarbon derivative / Imidazole
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
primary amino compound, imidazopyridine (CHEBI:76290)
Affected organisms
Not Available

Chemical Identifiers

UNII
909C6UN66T
CAS number
105650-23-5
InChI Key
UQVKZNNCIHJZLS-UHFFFAOYSA-N
InChI
InChI=1S/C13H12N4/c1-17-11-7-10(9-5-3-2-4-6-9)8-15-12(11)16-13(17)14/h2-8H,1H3,(H2,14,15,16)
IUPAC Name
1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine
SMILES
CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1

References

General References
Not Available
Human Metabolome Database
HMDB0041008
KEGG Compound
C16038
PubChem Compound
1530
PubChem Substance
99444869
ChemSpider
1476
ChEBI
76290
ChEMBL
CHEMBL1213271
ZINC
ZINC000001850101
PDBe Ligand
PIQ
Wikipedia
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
PDB Entries
1hz0 / 2qxm

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1WithdrawnBasic SciencePancreatic Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.416 mg/mLALOGPS
logP2.27ALOGPS
logP2.09Chemaxon
logS-2.7ALOGPS
pKa (Strongest Basic)5.12Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area56.73 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity68.59 m3·mol-1Chemaxon
Polarizability24.68 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.925
Caco-2 permeable+0.8867
P-glycoprotein substrateNon-substrate0.6643
P-glycoprotein inhibitor INon-inhibitor0.7789
P-glycoprotein inhibitor IINon-inhibitor0.6297
Renal organic cation transporterNon-inhibitor0.7021
CYP450 2C9 substrateNon-substrate0.8413
CYP450 2D6 substrateNon-substrate0.8509
CYP450 3A4 substrateNon-substrate0.5971
CYP450 1A2 substrateInhibitor0.9493
CYP450 2C9 inhibitorNon-inhibitor0.946
CYP450 2D6 inhibitorInhibitor0.7174
CYP450 2C19 inhibitorInhibitor0.5665
CYP450 3A4 inhibitorInhibitor0.5987
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.601
Ames testAMES toxic0.883
CarcinogenicityNon-carcinogens0.9431
BiodegradationNot ready biodegradable0.9883
Rat acute toxicity2.4617 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9194
hERG inhibition (predictor II)Non-inhibitor0.5736
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-006t-0920000000-32d0b5e415e1105fc11e
LC-MS/MS Spectrum - LC-ESI-QFT , negativeLC-MS/MSsplash10-00di-0090000000-efb76bf58f3994016cf1
MS/MS Spectrum - APCI-ITFT , negativeLC-MS/MSsplash10-0a4i-0090000000-b8fb35b55ad155cc7927
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-004i-0090000000-f3cfae76fa7ac8760463
MS/MS Spectrum - ESI-ITFT , positiveLC-MS/MSsplash10-004i-0090000000-19ebcab9e92cf28fe665
MS/MS Spectrum - APCI-ITFT , positiveLC-MS/MSsplash10-004i-0090000000-d014b289386a8225dce2
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0090000000-440ca6778dca09d9d0ae
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ue9-0900000000-3fb84227e39d9a61ab5f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0090000000-6c404117ca122f8083a7
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0fk9-0980000000-29467bb09caf72df40f4
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4j-0920000000-75e64b3ec3ba81f6d5b2
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0gbc-2910000000-b21e92a32afd9e9a7eab
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-159.7724608
predicted
DarkChem Lite v0.1.0
[M-H]-159.8604608
predicted
DarkChem Lite v0.1.0
[M-H]-159.8866608
predicted
DarkChem Lite v0.1.0
[M-H]-151.0447
predicted
DeepCCS 1.0 (2019)
[M+H]+159.6991608
predicted
DarkChem Lite v0.1.0
[M+H]+159.8158608
predicted
DarkChem Lite v0.1.0
[M+H]+159.7075608
predicted
DarkChem Lite v0.1.0
[M+H]+153.44026
predicted
DeepCCS 1.0 (2019)
[M+Na]+160.2589608
predicted
DarkChem Lite v0.1.0
[M+Na]+160.1993608
predicted
DarkChem Lite v0.1.0
[M+Na]+160.2242608
predicted
DarkChem Lite v0.1.0
[M+Na]+159.3528
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Zinc ion binding
Specific Function
Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissu...
Gene Name
ESR1
Uniprot ID
P03372
Uniprot Name
Estrogen receptor
Molecular Weight
66215.45 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Transcription coactivator activity
Specific Function
Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to ...
Gene Name
NCOA2
Uniprot ID
Q15596
Uniprot Name
Nuclear receptor coactivator 2
Molecular Weight
159155.645 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:31 / Updated at June 12, 2020 16:52